Stocks and Investing
Stocks and Investing
Mon, May 1, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Sun, April 30, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, April 28, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Aydin Huseynov Maintained (TPST) at Strong Buy with Increased Target to $14 on, Apr 28th, 2023
Aydin Huseynov of Ladenburg Thalmann, Maintained "Tempest Therapeutics, Inc." (TPST) at Strong Buy with Increased Target from $8 to $14 on, Apr 28th, 2023.
Aydin has made no other calls on TPST in the last 4 months.
There are 2 other peers that have a rating on TPST. Out of the 2 peers that are also analyzing TPST, 0 agree with Aydin's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Aydin
- Edward Tenthoff of "Piper Sandler" Maintained at Buy with Decreased Target to $6 on, Thursday, March 23rd, 2023
- Joseph Pantginis of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $35 on, Thursday, March 23rd, 2023
Contributing Sources